[1] Israël-Biet D, Bernardinello N, Pastré J,et al. High-risk sarcoidosis: a focus on pulmonary, cardiac, hepatic and renal advanced diseases, as well as on calcium metabolism abnormalities. J Diagnostics (Basel), 2024, 14(4):395. [2] 刘柯兵,赵萍,杨义春,等.肝脏局灶性结节增生的超声造影诊断表现.中国临床医学影像杂志,2021,32(6):423-425. [3] 崔新伍.中国学者参加欧洲超声联合会年会并参与制定世界超声联合会肝脏超声造影指南.中华超声影像学杂志,2019,28(7):594. [4] Liu H, Yao X, Xu B,et al. Efficacy and safety analysis of multislice spiral CT-guided transthoracic lung biopsy in the diagnosis of pulmonary nodules of different sizes. J Comput Math Methods Med, 2022, 2022:8192832. [5] Yang H, Lu L, Guo W,et al. A longitudinal study of AFP trajectories andclinical outcomes in intermediate-stage hepatocellular carcinoma after hepatectomy. J Hepatocell Carc, 2024, 11:219-228. [6] 中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版).中华消化外科杂志,2017,16(7):635-647. [7] Kobayashi S. Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics. World J Gastroenterol, 2021, 27(46):7894-7908. [8] Jin Y, Xu A. Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma. J Clin Lab Anal, 2024, 38(4):e25016. [9] Schizas D, Mastoraki A, Routsi E,et al. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary Pancreat Dis Int, 2020, 19(6):515-523. [10] Yu C, Sun C. Diagnostic value of multislice spiral computedtomography combined with serum AFP, TSGF, and GP73 assay in the diagnosis of primary liver cancer. Evid Based Complement Alternat Med, 2022, 2022:6581127. [11] Ferda J, Frölich M, Ferdová E,et al. Neovascularization, vascular mimicry and molecular exchange: the imaging of tumorous tissue aggressiveness based on tissue perfusion. Eur J Radiol, 2023, 163:110797. [12] Katayama Y, Uchino J, Chihara Y,et al. Tumor neovascularization and developments in therapeutics. Cancers (Basel), 2019, 11(3):316. [13] Senarathna J, Prasad A, Bhargava A,et al. HemoSYS: a toolkit for image-based systems biology of tumor hemodynamics. Sci Rep, 2020, 10(1):2372. [14] Jia P, Liu R, Liu Y,et al. Comparison of the value of colorDoppler ultrasound and multislice spiral CT in the differential diagnosis of benign and malignant nodules in the liver. Contrast Media Mol Imaging, 2022, 2022:5251966. [15] Gulati R, Hanlon MA, Lutz M,et al. Phosphorylation-mediated activation ofβ-catenin-TCF4-CEGRs/ALCDs pathway is an essential event in development of aggressive hepatoblastoma. Cancers (Basel), 2022, 14(24):6062. [16] Wijngaarden JE, Jauw YWS, Zwezerijnen GJC,et al. Non-specific irreversible89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET J. EJNMMI Res, 2024, 14(1):18. [17] Nair B, Kuriakose A, Baby B,et al. Tumor-specific growth factor (TSGF): a futuristic tumor biomarker in early diagnosis of cancer. Adv Pharm Bull, 2023, 13(3):483-488. [18] Johnson AM, Dudek JM, Edwards DK,et al. Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma. Expert Rev Mol Diagn, 2021, 21(11):1245-1252. [19] Eldosoky MA, Hammad R, Elmadbouly AA,et al. Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients. Int J Mol Sci, 2023, 24(4):3157. [20] Kong Y, Jing Y, Sun H,et al. The diagnostic value of contrast-enhanced ultrasound and enhanced CT combined with tumor markers AFP and CA199 in liver cancer. J Healthc Eng, 2022, 2022:5074571. |